Categories
CCSG

It’s finally September 24th

So, we finally had our NCI Site Visit yesterday. And, in my opinion, we were great! The uniform high quality of the presentations was very impressive. Each of our speakers conveyed mastery and personal command of their responsibilities, scientific virtuosity and a keen understanding of their respective roles in the function of the cancer center. Responses to the site visitors’ questions were spot-on. It was clear that our programs were vibrant, organic entities, and not mere administrative artifices. The Shared Resource presentations and tours were splendid. Everybody involved conveyed a sense of shared mission, meaningful community and a clear vision of what Lombardi is, and where it is headed. I have participated in many site visits, and have never been at one where all these elements were so fully and transparently on display. I am especially grateful to our fabulous Associate Directors and Program Leaders, other speakers and Shared Resource Directors whose tireless work was evident in the fine product that we presented. I am convinced that we portrayed ourselves accurately, and in a manner that should lead any reasonable deliberative body to conclude that we are most worthy of continued comprehensive designation for a period of five years. I am so proud of who we are, and what we have accomplished, and I am excited about our future.

I have never been at a site visit that has been better organized, or went so smoothly. Ellen McLaughlin and her team were utterly magnificent. Allison Whitney’s slides were fabulous. It is easy to take such things for granted, but I can assure you that nobody worked harder, including me, than they did to prepare the CCSG application and then assure that the site visit would highlight all the wonderful work that is done at Lombardi. I am immensely grateful for their work, and I know that you share my appreciation.

Our Senior Leadership team really coalesced to support me during these final hectic weeks. Even though Craig Jordan has only been here for a short time, his piercing insights and wise counsel contributed greatly to assure that I struck the right “tone” in my remarks to the reviewers. I am especially grateful to John Marshall for his masterful analysis and integration and compelling presentation of our clinical and clinical research activities. As always, Michael Vander Hoek was always there, working to make sure that all of the many moving parts fit. Moreover, he was the unsung hero of the site visit, responding to a last-minute request by the site reviewers to magically provide a whole new set of numbers for their review. Finally, Peter Shields has been my partner in crime since I arrived, as we prepared for yesterday. I shudder to think of where I would have been, or how we could have acquitted ourselves so well yesterday, without his experience, insights and knowledge of Lombardi.

Poor Phyllis! Can you imagine what she has had to put up with over the past year? At least Mia was there to provide her with consolation…

Categories
Research

Lombardi Welcomes Craig Jordan as Scientific Director

V. Craig Jordan, OBE, PhD, DSc
V. Craig Jordan, OBE, PhD, DSc

By now you’ll have seen the announcement that Craig Jordan will be joining us effective this July. I’m delighted to welcome him to Lombardi. He’s an old friend and colleague and I have witnessed firsthand his remarkable capacity to pull together diverse investigators in shared research enterprises. As Scientific Director, Craig will take a leading role in helping me to shape the research portfolio of the Cancer Center. He will be part of my senior operational leadership team, which will consist of Peter Shields in his role as Deputy Director, Michael Vander Hoek as Administrative Director, Craig as Scientific Director, and John Marshall as Clinical Director.

One of Craig’s most important tasks will be to identify opportunities for multi-investigator research programs and to help those programs coalesce and develop so they can be supported by traditional multi-investigator mechanisms such as P01s and SPOREs. I know that he is very excited about putting together a breast cancer SPORE effort working with our outstanding breast cancer investigators at Lombardi.

I was pleased when Claudine Isaacs and Bob Clarke initially approached me about trying to recruit Craig to Lombardi to take on a senior leadership role. They recognized his excellent fit with the breast cancer program at Lombardi. In his new role, Craig will have no specific programmatic leadership responsibilities, although his presence will certainly strengthen our breast cancer efforts here.

Craig will also have an important role in supporting fund raising efforts. His energy, charm, and wide experience will certainly prove to be great assets to Lombardi in that regard.

He will be visiting Lombardi to give a Visiting Professor Seminar in May. This will be a great opportunity for those of who you have not met him to learn more about his science. In the coming months there will be many additional opportunities for you to meet with Craig and learn more about his vision for his role as Scientific Director here at Lombardi.